MTVA

MetaVia Inc.
—

Company Information

Company Name
MetaVia Inc.
CIK
CIK0001638287
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
MTVA: Nasdaq
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2834
SIC Description
Pharmaceutical Preparations
Ticker
MTVA

SEC filing data through

Insider Sentiment

Last purchase
2025-06-04
Last sale
2024-09-12
Shares purchased (TTM)
9,751,147
Shares sold (TTM)
407
Buy ratio (TTM)100.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
259,473
Shares outstanding
5,931,875
Ownership
4.37%
-11.83% Y/Y

Earnings Market Reaction

Filing date
2026-08-06
Price on filing date
—
1-month reaction
17.24%
3-month reaction
…
Drift continued6/11 (55%)
Faded / reversed5/11 (45%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value131410141811162228162226
Prepaid Expense Current-----------0
Prepaid Expense And Other Assets Current00101100110-
Assets Current131411151812162229172326
Property Plant And Equipment Net000000000000
Operating Lease Right Of Use Asset000000000000
Other Assets Noncurrent000000000000
Assets131411151812162229172326
Liabilities Current
Accounts Payable Current111333413212
Accrued Liabilities Current---------442
Shares Subject To Mandatory Redemption Settlement Terms Amount Current000000011111
Other Liabilities Current233342134-1-
Operating Lease Liability Current000000000000
Liabilities Current6568988910765
Operating Lease Liability Noncurrent000-0000000-
Liabilities6568988910765
Stockholders Equity
Common Stock Value000000000000
Additional Paid In Capital165162154153153144144144144125125124
Retained Earnings Accumulated Deficit-158-153-149-147-144-140-136-131-125-115-108-103
Undesignated Preferred Stock----------0-
Stockholders Equity795610481319101722
Shared Services Agreement----------1-
Liabilities And Stockholders Equity131411151812162229172326
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized101010101010101010101010
Preferred Stock Shares Issued0000000000-0
Preferred Stock Shares Outstanding0000000000-0
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized100100100100100100100100100100100100
Common Stock Shares Issued75224249198555
Shares Outstanding75224249198555

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

MetaVia Inc. (MTVA) — SEC Financial Statements & Analysis

MetaVia Inc. (MTVA) is a pharmaceutical preparations company, incorporated in DE. MetaVia Inc. trades on Nasdaq as: MTVA. MetaVia Inc. (MTVA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, MetaVia Inc. carries a market cap of $8.48M, a P/E ratio of -0.59x, a P/B ratio of 1.24x, an enterprise value of $-4.15M, and an EV/EBITDA multiple of 0.28x. On profitability, it posts a Return on Equity (ROE) of -175.68% and a Return on Assets (ROA) of -91.06%. Per share, it reports EPS of $-2.44, diluted EPS of $-2.44, free cash flow per share of $-2.67, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -21.88% year-over-year and EPS growth of -81.70% year-over-year. On the balance sheet, it maintains a current ratio of 2.06x, a quick ratio of 1.99x, working capital of $6.72M, a debt-to-equity ratio of 0.95x, a debt ratio of 0.49, an interest coverage ratio of -37.90x, free cash flow of $-15.84M (TTM), and net debt of $-12.63M. Figures sourced from SEC EDGAR.

Market Cap
$8.48M
P/E TTM
-0.59x
EPS TTM
$-2.44
P/B TTM
1.24x
ROE TTM
-175.68%
ROA TTM
-91.06%
Debt To Equity
0.95x
Free Cash Flow TTM
$-15.84M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MetaVia Inc. in?

MetaVia Inc. (MTVA) operates in the Pharmaceutical Preparations industry.

What exchange does MTVA trade on?

MetaVia Inc. (MTVA) trades on the Nasdaq.

Where is MetaVia Inc. incorporated?

MetaVia Inc. is incorporated in DE.

When was MetaVia Inc. (MTVA)'s most recent SEC filing?

MetaVia Inc. (MTVA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.

What is MTVA's market cap?

MetaVia Inc. (MTVA) has a market capitalization of $8.48M as of 2026-06-30.

What is MTVA's EPS (earnings per share)?

MetaVia Inc. (MTVA)'s trailing twelve month EPS is $-2.44 as of 2026-06-30.

What is MTVA's ROE (return on equity)?

MetaVia Inc. (MTVA)'s trailing twelve month Return on Equity (ROE) is -175.68% as of 2026-06-30.

What is MTVA's ROA (return on assets)?

MetaVia Inc. (MTVA)'s trailing twelve month Return on Assets (ROA) is -91.06% as of 2026-06-30.

What is MTVA's EV/EBITDA?

MetaVia Inc. (MTVA)'s trailing twelve month EV/EBITDA is 0.28x as of 2026-06-30.

Wall Street's data.
Main Street's price.